Metformin is known to lower plasma glucose concentration by acting as an insulin sensitizer, improving fasting insulin levels and insulin-dependent hepatic glucose production, as well as increasing muscle glucose uptake, being one of the first-line antidiabetic drugs used for T2DM [55]. The gene discussed is INS; the disease is type 2 diabetes mellitus.